The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo
Open accessAbstract
Previously, stearyl triphenylphosphonium (STPP)-modified liposomes (STPP-L) were reported to target mitochondria. To overcome a non-specific cytotoxicity of STPP-L, we synthesized a novel polyethylene glycol- phosphatidylethanolamine (PEG-PE) conjugate with the TPP group attached to the distal end of the PEG block (TPP-PEG-PE). This conjugate was incorporated into the liposomal lipid bilayer, and the modified liposomes were studied for their toxicity, mitochondrial targeting, and efficacy in delivering paclitaxel (PTX) to cancer cells in vitro and in vivo. These TPP-PEG-PE-modified liposomes (TPP-PEG-L), surface grafted with as high as 8 mole % of the conjugate, were less cytotoxic compared to STPP-L or PEGylated STPP-L. At the same time, TPP-PEG-L demonstrated efficient mitochondrial targeting in cancer cells as shown by confocal microscopy in co-localization experiments with stained mitochondria. PTX-loaded TPP-PEG-L demonstrated enhanced PTX-induced cytotoxicity and anti-tumor efficacy in cell culture and mouse experiments compared to PTX-loaded unmodified plain liposomes (PL). Thus, TPP-PEG-PE can serve as a targeting ligand to prepare non-toxic liposomes as mitochondria-targeted drug delivery systems (DDS).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Self-citationDeletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
Holt, I. J., Harding, A. E., & Morgan-Hughes, J. A. (1988) · Nature · doi:10.1038/331717a0 · Cited by 1,846
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
Gabizon, A., & Papahadjopoulos, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6949 · Cited by 1,131
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
Mitochondrial mutations in cancer
Brandon, M., Baldi, P., & Wallace, D. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209607 · Cited by 818
Delivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
Conversion of Bcl-2 from Protector to Killer by Interaction with Nuclear Orphan Receptor Nur77/TR3
Lin, B., Kolluri, S. K., Lin, F., Liu, W., Han, Y.-H., Cao, X., Dawson, M. I., Reed, J. C., & Zhang, X.-K. (2004) · Cell · doi:10.1016/s0092-8674(04)00162-x · Cited by 671
Cytochrome c Release and Apoptosis Induced by Mitochondrial Targeting of Nuclear Orphan Receptor TR3
Li, H., Kolluri, S. K., Gu, J., Dawson, M. I., Cao, X., Hobbs, P. D., Lin, B., Chen, G.-Q., Lu, J.-S., Lin, F., et al. (2000) · Science · doi:10.1126/science.289.5482.1159 · Cited by 667
Hoye, A. T., Davoren, J. E., Wipf, P., Fink, M. P., & Kagan, V. E. (2008) · Accounts of Chemical Research · doi:10.1021/ar700135m · Cited by 636
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury
Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., & Sammut, I. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3718com · Cited by 618
Targeting lipophilic cations to mitochondria
Murphy, M. P. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.03.029 · Cited by 598
RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETING
Torchilin, V. P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095735 · Cited by 543
Self-citationMicrotubule-targeted anticancer agents and apoptosis
Bhalla, K. N. (2003) · Oncogene · doi:10.1038/sj.onc.1207233 · Cited by 461
Jauslin, M. L., Meier, T., Smith, R. A. J., & Murphy, P. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0240fje · Cited by 358
Mitochondria and Cancer: Warburg Addressed
WALLACE, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.035 · Cited by 285
Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF)
Norberg, E., Orrenius, S., & Zhivotovsky, B. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.163 · Cited by 268
No death without life: vital functions of apoptotic effectors
Galluzzi, L., Joza, N., Tasdemir, E., Maiuri, M. C., Hengartner, M., Abrams, J. M., Tavernarakis, N., Penninger, J., Madeo, F., & Kroemer, G. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.28 · Cited by 257
Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome
Yang, T., Choi, M.-K., Cui, F.-D., Kim, J. S., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.011 · Cited by 245
Saad, M., Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., & Minko, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.024 · Cited by 238
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel
Immordino, M. L., Brusa, P., Arpicco, S., Stella, B., Dosio, F., & Cattel, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00271-2 · Cited by 238
Boddapati, S. V., D’Souza, G. G. M., Erdogan, S., Torchilin, V. P., & Weissig, V. (2008) · Nano Letters · doi:10.1021/nl801908y · Cited by 234
Self-citationHorobin, R. W., Trapp, S., & Weissig, V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.040 · Cited by 172
Paclitaxel Directly Binds to Bcl-2 and Functionally Mimics Activity of Nur77
Ferlini, C., Cicchillitti, L., Raspaglio, G., Bartollino, S., Cimitan, S., Bertucci, C., Mozzetti, S., Gallo, D., Persico, M., Fattorusso, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0540 · Cited by 165
Mironov, S. L., Ivannikov, M. V., & Johansson, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409819200 · Cited by 164
Flierl, A., Jackson, C., Cottrell, B. A., Murdock, D. G., Seibel, P., & Wallace, D. C. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00037-6 · Cited by 151
Boddapati, S. V., Tongcharoensirikul, P., Hanson, R. N., D’Souza, G. G. M., Torchilin, V. P., & Weissig, V. (2005) · Journal of Liposome Research · doi:10.1081/lpr-64958 · Cited by 131
Self-citationCytoplasmic delivery and nuclear targeting of synthetic macromolecules
Jensen, K. D., Nori, A., Tijerina, M., et al. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00352-8 · Cited by 124
Yamada, Y., Akita, H., Kogure, K., Kamiya, H., & Harashima, H. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.12.003 · Cited by 118
Effective intracellular delivery of oligonucleotides in order to make sense of antisense
Shi, F., & Hoekstra, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.016 · Cited by 111
Chen, X., Wang, X., Wang, Y., Yang, L., Hu, J., Xiao, W., Fu, A., Cai, L., Li, X., & Ye, X. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.007 · Cited by 99
Biswas, S., Dodwadkar, N. S., Sawant, R. R., Koshkaryev, A., & Torchilin, V. P. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.536983 · Cited by 86
Self-citationMitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol
Patel, N. R., Hatziantoniou, S., Georgopoulos, A., Demetzos, C., Torchilin, V. P., Weissig, V., & D’Souza, G. G. M. (2009) · Journal of Liposome Research · doi:10.3109/08982100903347931 · Cited by 81
Self-citationIntracellular organelle-targeted non-viral gene delivery systems
Won, Y.-W., Lim, K. S., & Kim, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.013 · Cited by 75
Cationic amphiphilic polyproline helix P11LRR targets intracellular mitochondria
Li, L., Geisler, I. M., Chmielewski, J. A., & Cheng, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.012 · Cited by 59
Novel HPMA Copolymer-Bound Constructs for Combined Tumor and Mitochondrial Targeting
Cuchelkar, V., Kopečková, P., & Kopec̆ek, J. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800019g · Cited by 57
Weyland, M., Manero, F., Paillard, A., Gree, D. M., Viault, G., Jarnet, D., Meneï, P., Juin, P. P., Chourpa, I., Benoît, J., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.032 · Cited by 35
Laquintana, V., Denora, N., Musacchio, T., Lasorsa, F. M., Latrofa, A., & Trapani, G. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.007 · Cited by 30
In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins
Stefano, J. E., Hou, L., Honey, D. M., Kyazike, J., Park, A., Zhou, Q., Pan, C. Q., & Edmunds, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.006 · Cited by 12
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Self-citationNanoparticles as drug delivery systems
Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445
Insight into nanoparticle cellular uptake and intracellular targeting
Yameen, B., Choi, W. I., Vilos, C., Swami, A., Shi, J., & Farokhzad, O. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.038 · Cited by 787
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Self-citation
Metadata
- Authors
- Biswas, S., Dodwadkar, N. S., Deshpande, P. P., & Torchilin, V. P.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 159
- Issue
- 3
- Pages
- 393-402
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2021680808
- Cited by
- 279
- References
- 45
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.